Ear Infection Treatment Companies

Latest Ear Infection Treatment Companies Update

• 
  Sep 2023: The exclusive evaluation and option agreement between MustGrow Biologics Corp. and Janssen PMP, a subsidiary of Janssen Pharmaceutica NV, one of the Janssen drug companies of Johnson & Johnson, has been significantly expanded to include testing and development of MustGrow's biological mustard plant-based technologies for specific postharvest food preservation storage applications worldwide. The Agreement, on a worldwide scale, will now cover postharvest tubers and bananas. Postharvest potatoes and bananas were not included in the initial evaluation process as per the Agreement. Nevertheless, after completing a quarter-year postharvest evaluation project with the aid of MustGrow's technology, Janssen PMP and MustGrow have generated highly positive and effective outcomes, bolstering the choice to include postharvest bananas and potatoes in Janssen PMP's exclusive assessment activity.

• 
  Jan 2023: The Japanese manufacturer of medical devices, Olympus Corp., announced that it was responding to the U.S. health regulator's concerns on infractions discovered during an inspection of the company's Japanese plants. The U.S. Food and Drug Administration declared that it had cited infractions at its facilities and had sent warning letters to Olympus' operations about a class of equipment known as endoscopes. Olympus announced that it was modifying the quality control procedures at its locations. A corporate representative responded via email to a query and stated that responses to every warning letter had been sent to the FDA and that work on fixing the problems was continuing.

• Sanofi S.A. (France)


• Novartis International AGF (Switzerland)


• Janssen Pharmaceutica (Belgium)


• Abbott Laboratories (US)


• Pfizer Inc. (US)


• Medtronic PLC (US)


• Olympus Corporation (Japan)


• Torque Pharmaceuticals Pvt. Ltd. (India)


• American Diagnostic Corporation (US)


• Intersect ENT Inc. (US)


• Heine USA Ltd. (US)